Watchlist Price Alert

Hancock Jaffe Laboratorie... (HJLIW)

NASDAQ: HJLIW · Real-Time Price · USD

0.56

0.09 (20.38%)

At close: Oct 01, 2021, 4:00 AM

Hancock Jaffe Laboratories Warrants Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q4 2016
Period Ending	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Dec 31, 2016
Cash & Equivalents	41.04M	43.84M	9.33M	5.63M	1.56M	720.13K	1.31M	2.94M	4.47M	2.75M	2.74M	4.19M	5.94M	309.13K	77.69K	311.48K	15.92K	56.51K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	34.99K	29.84K	n/a	n/a	1.52M	1.6M	1.67M	1.73M	1.8M	1.87M	29.84K	29.84K	29.84K	1.25M	911.22K	224.43K	1.34M	128.12K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	26.52K	32.02K	28.06K	28.96K	31.07K	35.18K	105.62K	198.8K	189.75K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	90.91K
Other Current Assets	399.69K	328.84K	234.47K	348.65K	220.81K	120.01K	116.65K	116.85K	164.59K	166.61K	64.31K	146.66K	137.63K	106.74K	57.54K	131.86K	157.05K	56.05K
Total Current Assets	41.44M	44.17M	9.57M	5.98M	1.78M	840.14K	1.42M	3.06M	4.63M	2.95M	2.84M	4.36M	6.11M	446.94K	170.41K	548.96K	371.76K	393.22K
Property-Plant & Equipment	878.27K	859.29K	398.97K	425.53K	426.85K	329.66K	344.03K	350.26K	194.03K	24.89K	26.15K	24.85K	19.08K	21.46K	23.84K	17.6K	19.82K	28.81K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	608.23K	627.65K	647.06K	666.47K	1.02M	1.05M	1.08M	1.11M	1.14M	n/a	1.23M
Total Long-Term Assets	913.26K	889.13K	398.97K	425.53K	1.95M	1.93M	2.01M	2.69M	2.62M	2.54M	722.46K	1.07M	1.1M	2.35M	2.04M	1.38M	1.36M	1.39M
Total Assets	42.35M	45.05M	9.97M	6.4M	3.73M	2.77M	3.43M	5.75M	7.25M	5.49M	3.56M	5.44M	7.21M	2.8M	2.21M	1.93M	1.73M	1.78M
Account Payables	308.88K	709.24K	1.39M	974.23K	1.57M	1.4M	1.22M	1.21M	1.2M	1.1M	1.08M	1.22M	1.36M	1.5M	1.45M	766.33K	791.33K	541.96K
Deferred Revenue	33K	n/a	33K	33K	33K	33K	33K	30.27K	26.22K	27.11K	n/a	n/a	49K	103.4K	103.4K	n/a	n/a	n/a
Short-Term Debt	638.97K	632.93K	626.9K	620.52K	614.14K	258.81K	288.69K	271.1K	271.1K	271.1K	n/a	n/a	25.61K	4.7M	2.62M	1.67M	1.04M	632.77K
Other Current Liabilities	412.47K	531.75K	1.14M	287.67K	738.59K	563.21K	333.44K	502.9K	388.77K	444.43K	n/a	n/a	-25.61K	7.07M	4M	3.09M	1.69M	891.86K
Total Current Liabilities	1.39M	1.87M	3.19M	1.92M	2.95M	2.25M	1.88M	2.02M	1.88M	1.84M	1.08M	1.22M	1.41M	13.37M	8.17M	5.53M	3.52M	2.07M
Long-Term Debt	84.58K	169.16K	n/a	n/a	410.85K	531.51K	567.95K	651.84K	718.15K	784.46K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	253.75K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.17M	5.17M	4.57M	4.57M	3.94M
Total Long-Term Liabilities	84.58K	169.16K	253.75K	n/a	410.85K	531.51K	567.95K	651.84K	718.15K	784.46K	n/a	n/a	n/a	5.17M	5.17M	4.57M	4.57M	3.94M
Total Liabilities	1.48M	2.04M	3.44M	2.25M	3.36M	2.78M	2.44M	2.67M	2.6M	2.62M	1.52M	1.89M	2.6M	18.54M	13.35M	10.09M	8.09M	6M
Total Debt	723.55K	802.1K	314.2K	307.82K	1.02M	790.32K	856.63K	922.94K	989.25K	1.06M	n/a	n/a	n/a	4.7M	2.62M	1.67M	1.04M	632.77K
Common Stock	85.00	85.00	25.00	403.00	240.00	192.00	179.00	179.00	179.00	141.00	117.00	117.00	117.00	61.00	61.00	61.00	122.00	122.00
Retained Earnings	-70.47M	-68.1M	n/a	n/a	-58.97M	-57.35M	-56.19M	-53.9M	-52.08M	-50.14M	-48.56M	-46.78M	-45.31M	-40.27M	-35.52M	-32.4M	-30.14M	-27.73M
Comprehensive Income	n/a	-515.52K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-362.94K	n/a	n/a	-372.99K
Shareholders Equity	40.87M	43.01M	7.1M	4.79M	369.44K	-14.62K	989.94K	3.08M	4.65M	2.87M	2.04M	3.54M	4.61M	-15.74M	-11.13M	-8.16M	-6.36M	-4.22M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a